Your browser doesn't support javascript.
loading
CRIP1 suppresses BBOX1-mediated carnitine metabolism to promote stemness in hepatocellular carcinoma.
Wang, Jing; Zhou, Yan; Zhang, Donghui; Zhao, Weiyi; Lu, Yishi; Liu, Chaoqun; Lin, Wandie; Zhang, Yujie; Chen, Kunling; Wang, Hui; Zhao, Liang.
Afiliación
  • Wang J; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhou Y; Department of Pathology & Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Zhang D; Department of Medical Oncology, Affiliated Tumour Hospital of Guangzhou Medical University, Guangzhou, China.
  • Zhao W; Department of Pathology, Affiliated Tumour Hospital of Guangzhou Medical University, Guangzhou, China.
  • Lu Y; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Liu C; Department of Pathology & Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Lin W; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhang Y; Department of Pathology & Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Chen K; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Wang H; Department of Pathology & Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Zhao L; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
EMBO J ; 41(15): e110218, 2022 08 01.
Article en En | MEDLINE | ID: mdl-35775648
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Portadoras / Carcinoma Hepatocelular / Gamma-Butirobetaína Dioxigenasa / Proteínas con Dominio LIM / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: EMBO J Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Portadoras / Carcinoma Hepatocelular / Gamma-Butirobetaína Dioxigenasa / Proteínas con Dominio LIM / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: EMBO J Año: 2022 Tipo del documento: Article País de afiliación: China